DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for bursitis — screening already-approved drugs against its 12-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleBursitis maps to a 12-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for bursitis is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
interleukin 6 (IL6) — IL6 is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet +drag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 1ALU · 1.9 Å · ligand L(+)-TARTARIC ACID (TLA). Experimental structure, not a prediction.
What the evidence adds up to
In a 2011 trial of 462 patients with rotator cuff calcific tendinitis, warm saline (42°C) was compared with room-temperature saline during ultrasound-guided double-needle lavage. Procedure duration was shorter with warm saline (mean 576 seconds versus 777 seconds), and calcium dissolution was rated easier (median score 1 versus 2). Postprocedural bursitis occurred in 8 patients in the warm saline group and 20 in the room-temperature group. However, pain scores on a visual analogue scale did not differ significantly between groups at any time point up to one year. Operators and patients were not blinded to saline temperature.
A 1978 letter reported two cases of septic bursitis (one prepatellar, one bilateral olecranon) from which Staphylococcus aureus was cultured. Both involved trauma without skin breakage or fracture. The authors noted that previous textbooks had described a low incidence of septic bursitis, but their recent experience suggested a surprisingly high rate among patients presenting with acute bursitis.
A 1963 review stated that anti-inflammatory agents, both steroid and nonsteroid, had improved the management of bursitis and related tendon and ligament lesions. A 2024 chapter on nutraceuticals asserted that many such compounds have anti-inflammatory effects that could help manage bursitis, but provided no patient data or trial results. A 2025 review summarised that bursitis arises from repetitive trauma, infections, rheumatic diseases, and other conditions; diagnostic methods range from clinical examination to ultrasound and MRI; and treatment trends favour conservative approaches such as physiotherapy, with surgery reserved for severe cases.
What is still missing are randomised controlled trials of any drug specifically for non-septic, non-calcific bursitis; data on whether nutraceuticals alter clinical outcomes in any form of bursitis; and any trial that stratifies patients by bursitis type, chronicity, or underlying cause. No drug has been shown in a controlled trial to prevent or cure bursitis.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Radiology · 2011 · 92 citations
Rotator Cuff Calcific Tendinitis: Does Warm Saline Solution Improve the Short-term Outcome of Double-Needle US-guided Treatment?
AbstractPURPOSE: To determine whether saline temperature influences procedure performance and outcome in patients undergoing ultrasonography (US)-guided lavage for the treatment of rotator cuff calcific tendinitis (RCCT). MATERIALS AND METHODS: This study was approved by the institutional review board, and informed consent was obtained from all patients. From December 2009 to May 2011, 462 patients (191 men and 271 women; mean age, 39.7 years) with painful RCCT diagnosed at US were prospectively enrolled and randomized into two groups. Operators subjectively classified calcifications as hard, soft, or fluid according to their appearance at US. US-guided percutaneous treatment of RCCT (local anesthesia, double-needle lavage, intrabursal steroid injection) was performed with warm saline (42°C, 107°F) in 229 patients and with room-temperature saline in 233. Operators and patients were not blinded to saline temperature. The ease of calcium dissolution was subjectively scored (easy=1, intermediate=2, difficult=3). Procedure duration was recorded. Patient discomfort was assessed by using a visual analog scale (VAS). The occurrence of postprocedure bursitis was recorded. Statistical analyses were performed with Mann-Whitney U, χ2, and analysis of variance tests. RESULTS: Procedure duration was significantly shorter (P<.001) in patients treated with warm saline (mean, 576 seconds±121) than in those treated with room-temperature saline (mean, 777 seconds±151). Calcium dissolution was significantly easier in patients treated with warm saline (median score, 1) than in those treated with room-temperature saline (median score, 2). Subgroup analysis according to calcification appearance at US showed a significant difference between groups for both soft (P=.003) and hard (P<.001) calcifications. No overall significant differences were found for VAS score (warm saline group: baseline=8.9±0.6, 1 month=4.7±0.6, 2 months=4.0±0.7, 3 months=3.4±0.4, 1 year=3.0±0.7; room-temperature saline group: baseline=9.2±0.4, 1 month=4.5±0.7, 2 months=4.1±0.9, 3 months=3.1±0.7, 1 year=3.2±0.8; P=.491). Postprocedural bursitis was observed in eight patients in the warm saline group and 20 in the room-temperature saline group (P<.022). CONCLUSION: In the treatment of RCCT, warm saline appears to reduce procedure duration and improve calcification dissolution while reducing the frequency of postprocedural bursitis.
AbstractLetters and Correction1 December 1978Septic BursitisJAMES A. ENGELBRECHT, M.D., MARK MUELLER, M.D.JAMES A. ENGELBRECHT, M.D.Search for more papers by this author, MARK MUELLER, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-89-6-1011_3 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: We have read with interest the article on septic bursitis (Ann Intern Med 89:21-27, 1978). Previous anecdotal reports indicated a low incidence of septic bursitis, and most current textbooks reflect this "dogma." Our recent experience suggests a surprisingly high incidence of infected bursae in patients presenting with acute bursitis.In the past 2 months we have seen two patients with bursitis (one with prepatellar and one with bilateral olecranon) from whichStaphylococcus aureuswas cultured. Each case involved trauma to the area but no evidence of skin breakage or fracture. Interestingly, the prepatellar bursitis occurred in a... This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: JAMES A. ENGELBRECHT, M.D.; MARK MUELLER, M.D.Affiliations: Veterans Administration Hospital Salt Lake City, UT 84148 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited bySeptic olecranon bursitis, contact dermatitis, and pneumonitis in a gas turbine engine mechanicOlecranon and pretibial bursitis in atopic dermatitis: Coincidence or association?Predisposing Factors, Bacteriology and Antibiotic Therapy in 35 Cases of Septic Bursitis 1 December 1978Volume 89, Issue 6Page: 1011-1011KeywordsStaphylococcus aureus ePublished: 1 December 2008 Issue Published: 1 December 1978 PDF downloadLoading ...
New England Journal of Medicine · 1963 · 1 citations
Management of Bursitis
AbstractTHE dictionary definition of "bursitis" limits one to discussion of inflammatory processes in bursas alone. In the lay mind this term also embraces certain traumatic and degenerative lesions involving tendons, tendon sheaths, ligaments and the several structures of joint capsules. In this latter, more inclusive sense the term is used here.Since the ability to deal with common afflictions of these structures has been dramatically improved in recent years with the addition of the anti-inflammatory agents, both steroid and nonsteroid, to the therapeutic armamentarium, a brief review of these several conditions and concepts in their management seems in order.Bursas . . .
Role of Nutraceuticals in Prevention and Management of Bursitis
AbstractBursitis is a typical reason for outer muscle torment and frequently prompts muscular interview. Bursitis should be recognized from joint inflammation, crack, tendinitis, and nerve pathology. Normal kinds of bursitis incorporate prepatellar, olecranon, trochanteric, and retrocalcaneal. Inflammation is a part of the ordinary host guard instrument that gives assurance from contamination and different affronts. Irritation starts the killing of microorganisms and is associated with the cycles of tissue fix as supporting rebuilding of homeostasis at tainted or harmed destinations. The fiery reaction includes cooperation among numerous cell types and the creation of, and reactions to, various compound. These in-betweens are harming to microbes however may likewise make harm to tissues. It is the inundation of cells into the site of fiery movement and the presence of the provocative go between delivered accordingly that are liable for the cardinal indications of irritation: redness, expanding, hotness, torment and loss of capacity. One of the self-improvement solutions to joint fix is monitoring muscle to fat ratio, getting movement and work out, and keeping up with great nutritive dietary plans. Although ongoing drug progresses have further developed treatment of joints, patients with related issues frequently ask about dietary mediations/sources for further development, as they see quick changes in their indications after utilization of specific food varieties. Many nutraceuticals have been proven to have anti-inflammatory effect which can in turn help in the management of bursitis. In this chapter we have discussed some of the significant nutraceutical and their role in the prevention and treatment of bursitis.
Journal of Advances in Medicine and Medical Research · 2025 · 0 citations · open access
Redeveloping Bursitis from a Polymorphic View: Definitions, Types, Treatments and State of the Art
AbstractThis study proposed a comprehensive review on the subject of bursitis, an inflammatory condition of the synovial bursae that is often overlooked or underestimated. A literature review investigated the definitions, types, treatments and state of the art of bursitis and provided an up-to-date overview for health professionals and researchers. With this in mind, the general objective was to comprehensively investigate and describe bursitis, including definitions, types, treatments and the current state of the art. The specific objectives were to identify the different types of bursitis and their distinctive characteristics; to analyze the methods of diagnosing and assessing bursitis; to review the treatment options available, including conservative and surgical approaches; and to examine the current state of research and future prospects in the field of bursitis. The methodology used was a qualitative, bibliographical, and exploratory study of the Integrative Literature Review (ILR) type. The results showed that repetitive trauma, infections, rheumatic diseases and other underlying conditions were among the factors contributing to the development of bursitis. Different types of bursitis were identified, each with different clinical characteristics and therapeutic approaches. Diagnostic methods range from simple clinical examinations to advanced imaging modalities such as ultrasound and magnetic resonance imaging. As for treatments, there has been a growing trend towards conservative approaches such as physiotherapy, although surgery is still considered in severe cases.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
